Cure Spg4 Foundation Inc is located in San Antonio, TX. According to its NTEE Classification (G20) the organization is classified as: Birth Defects & Genetic Diseases, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Cure Spg4 Foundation Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
OUR MISSION IS TO INCREASE AWARENESS OF SPG4 HEREDITARY SPASTIC PARAPLEGIA, PROVIDE A RESOURCE FOR PATIENTS AND THEIR FAMILIES, AND FUND RESEARCH TO FIND A CURE FOR SPG4 HEREDITARY SPASTIC PARAPLEGIA.
Describe the Organization's Program Activity:
Part 3 - Line 4a
FUNDED $161,500 IN RESEARCH GRANTS TO SUPPORT POTENTIAL THERAPIES FOR SPG4 HEREDITARY SPASTIC PARAPLEGIA, INITIATED THE FORMATION OF A CENTRALIZED SPG4 BIOBANK THROUGH CORIELL INSTITUTE
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Andrea Mcdonnell President | OfficerTrustee | 4 | $0 |
Erin Dear Treasurer | OfficerTrustee | 4 | $0 |
Cuyler Dear Vice President | OfficerTrustee | 1 | $0 |
Daniel Mcdonnell Secretary | OfficerTrustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $275,161 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $275,161 |
Total Program Service Revenue | $0 |
Investment income | $0 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $11,460 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $286,621 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $161,500 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $0 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $0 |
Advertising and promotion | $0 |
Office expenses | $2,533 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $0 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $0 |
All other expenses | $0 |
Total functional expenses | $164,033 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $132,305 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $132,305 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $0 |
Net assets without donor restrictions | $132,305 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $132,305 |
Over the last fiscal year, Cure Spg4 Foundation Inc has awarded $161,500 in support to 3 organizations.
Grant Recipient | Amount |
---|---|
DREXEL UNIVERSITY PURPOSE: SPG4 Gene Therapy | $75,000 |
NORTHWESTERN UNIVERSITY PURPOSE: NU-9 in vitro studies | $46,500 |
UMASS MEDICAL SCHOOL FOUNDATI PURPOSE: Carrier Cattle - SPG4 Gene Therapy | $40,000 |